Invention Grant
- Patent Title: N1/N2-lactam acetyl-CoA carboxylase inhibitors
- Patent Title (中): N1 / N2-内酰胺乙酰辅酶A羧化酶抑制剂
-
Application No.: US14497396Application Date: 2014-09-26
-
Publication No.: US08993586B2Publication Date: 2015-03-31
- Inventor: David A. Griffith , Robert L. Dow , Scott W. Bagley , Aaron Smith
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent James T. Wasicak
- Main IPC: C07D471/20
- IPC: C07D471/20 ; A61K31/438
Abstract:
The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein G is R1, R2 and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
Public/Granted literature
- US20150025098A1 N1/N2-LACTAM ACETYL-COA CARBOXYLASE INHIBITORS Public/Granted day:2015-01-22
Information query
